NovoCure (NVCR) Shares Issued (2014 - 2026)

NovoCure has disclosed Shares Issued across 13 years of filings, most recently posting $390000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $390000.0, down 92.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $146000.0 (down 98.46% YoY), and the FY2025 annual result was $3.7 million, down 11.9% from the prior year.
• Shares Issued came in at $390000.0 for Q1 2026 at NovoCure, up from -$2.4 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $8.5 million in Q4 2023 to a low of -$2.4 million in Q4 2025.
• The 5-year median for Shares Issued is $2.0 million (2024), against an average of $2.0 million.
• Peak annual rise in Shares Issued reached 244.75% in 2023, while the deepest fall reached 498.46% in 2023.
• NovoCure's Shares Issued stood at $2.5 million in 2022, then surged by 244.75% to $8.5 million in 2023, then slumped by 76.9% to $2.0 million in 2024, then plunged by 221.24% to -$2.4 million in 2025, then surged by 116.39% to $390000.0 in 2026.
• The last three Shares Issued figures came in at $390000.0 (Q1 2026), -$2.4 million (Q4 2025), and $2.1 million (Q2 2025), per Business Quant data.